Real-time prescription monitoring: state-by-state guide

Understanding Australia's evolving RTPM landscape and regulatory obligations

Published 3 April 2026

Introduction

Real-time prescription monitoring (RTPM) systems have fundamentally altered how Australian prescribers and pharmacists manage controlled substances and high-risk medications. For insurance professionals adjudicating medication-related claims, understanding these systems is essential to assessing prescriber behaviour, identifying potential medication misuse, and evaluating claim legitimacy.

Australia's approach to RTPM is fragmented by jurisdiction, with each state and territory maintaining distinct systems, access protocols, and regulatory frameworks. This complexity creates compliance risks and operational challenges that directly impact claim outcomes.

The SafeScript Foundation

Victoria's SafeScript system, launched in 2019, established the template for real-time prescription monitoring in Australia. The system requires prescribers to check a patient's prescription history before dispensing Schedule 8 (opioids, stimulants, benzodiazepines) and Schedule 4 restricted medicines.

SafeScript processes approximately 18 million transactions annually and has identified thousands of patients with patterns consistent with medication misuse or doctor shopping. For insurance claims, SafeScript data provides objective evidence of prescribing patterns that may indicate secondary psychological injury, medication dependence, or iatrogenic harm.

State-by-State Regulatory Framework

Prescriber Obligation and Compliance

Mandatory vs. Voluntary Systems

Victoria's SafeScript is the only truly mandatory RTPM system in Australia. Prescribers must check patient prescription history before issuing Schedule 8 or Schedule 4 restricted medications. Failure to comply incurs regulatory sanctions from the Medical Board of Australia and potential indemnity liability.

In other jurisdictions, prescriber access is typically voluntary or incentivised through professional guidelines. This creates a compliance gradient: prescribers in Victoria operate under strict regulatory scrutiny, while those in Queensland or South Australia may have minimal real-time accountability.

Access and Data Governance

Who Can Access RTPM Data?

• Prescribers (licensed medical practitioners and eligible nurse practitioners)
• Pharmacists (for dispensing verification)
• Regulatory authorities (TGA, State Pharmacy Boards)
• Law enforcement (with warrant or authority)
• Insurance providers (restricted access, case-by-case basis)

Insurance professionals typically cannot directly access RTPM data. Instead, data flows into claim files through: claimant self-disclosure, prescriber reports, pharmacy records obtained via release of information, and regulatory correspondence.

Privacy and Consent Requirements

All RTPM access is governed by state health privacy legislation and the Privacy Act 1988 (Cth). Insurance professionals must obtain explicit written consent from claimants before requesting RTPM-derived information from pharmacies or prescribers. Coercive consent frameworks (linking consent to claim progression) may breach privacy principles and create dispute liability.

Risk Assessment Applications

Identifying Prescriber Behavioural Patterns

RTPM data reveals prescriber patterns that carry claim risk implications. Common patterns include: polypharmacy clustering (prescribing multiple depressants concurrently), dose escalation without clinical justification, prescribing across multiple patients with identical medication combinations, and supply continuity patterns that suggest medication diversion.

A prescriber with high-frequency, high-dose opioid prescriptions combined with benzodiazepine co-prescription may face TGA scrutiny, but more importantly for insurance claims, indicates elevated risk of secondary psychological injury, opioid-induced depression, and long-term medication dependency in claimants.

Medication Misuse Red Flags

RTPM systems identify claimants obtaining Schedule 8 medications from multiple prescribers concurrently (doctor shopping), obtaining medications beyond therapeutic dosing windows, or presenting patterns consistent with medication diversion. These flags directly support claim cost containment and inform medication review prioritisation.

Integration with Medication Reviews

Pharmacist-led medication reviews, when informed by RTPM data, provide higher-quality clinical intelligence for insurers. Reviewers can identify prescribing inconsistencies, assess concordance between RTPM history and current medication list, and detect medication switching patterns that indicate clinical instability or iatrogenic harm.

RTPM data is most valuable when integrated early in the claim lifecycle. Insurance teams should flag potential RTPM concerns during registration and request medication reviews that explicitly reference available prescription history.

Compliance and Regulatory Risk

Prescriber Discipline and De-registration

RTPM systems support regulatory action against high-risk prescribers. In Victoria, Medical Board investigations increasingly incorporate SafeScript data showing prescribers with outlier patterns. De-registered or suspended prescribers create significant liability for insurers, as claims may be disputed based on prescriber credibility.

Insurance Provider Liability

Insurers have emerging liability exposure if medication-related harm results from failure to access available RTPM data. Workers compensation and CTP claims involving medication injury may trigger negligence arguments if RTPM information was available but not obtained. Document access attempts and reasoning in claim files.

Future Developments

The Pharmacy Board of Australia and AHPRA are progressing national harmonisation of RTPM systems. Schedule 4 expansion is planned for Victoria (2027), with other jurisdictions likely to follow. Integrated access for authorised insurance professionals is under discussion but remains unlikely in the near term due to privacy concerns.

Interstate prescriber mobility is increasing RTPM complexity. Patients obtaining medications across state borders create data fragmentation. Insurance teams should request comprehensive pharmacy records encompassing all known prescriber relationships and pharmacies, regardless of geographic jurisdiction.